Monitoring of Disease Modifying Antirheumatic Drugs (DMARDs)

Commissioning Lead: Linda Cutter, Head of Commissioning - Elective Care, Sheffield CCG

Published Date: August 2019

Date to Review: February 2024

Description: Shared care protocols for the Monitoring of Oral Disease Modifying Antirheumatic Drugs (DMARDs) Methotrexate (oral or subcutaneous), Leflunomide, Azathioprine, Mycophenolate Mofetil and Mercaptopurine & Monitoring of Disease Modifying Antirheumatic Drugs (DMARDs) (Gold Injections)

https://www.intranet.sheffieldccg.nhs.uk/medicines-prescribing/shared-care-protocols.htm